Given the success of Research Topic
The Impact of Adipose Tissue Dysfunction on Cardiovascular and Renal Disease and the rapidly evolving subject area, we are pleased to announce the launch of Volume II.
Obesity is associated with adverse metabolic diseases, including cardiovascular disease (CVD) and chronic kidney disease (CKD). These obesity-related diseases were believed to be highly associated with excess fat accumulation in adipose tissue. However, emerging evidence has shown that body fat distribution plays a more important role in body metabolism and obesity-related metabolic diseases, compared with fat accumulation itself. Previous studies have focused mainly on classical visceral adipose tissue and subcutaneous adipose tissue. However, other adipose tissues around vessels, including perivascular adipose, perirenal adipose tissues, and epicardial tissues, have attracted much attention recently. This adipose tissue dysfunction has shown to be associated with a higher risk of CVD and CKD in obesity and metabolic syndrome. However, little is known about the mechanisms underlying this potential association. Hence, studies on the relationship of various adipose tissue dysfunction to metabolism-related diseases are of utmost importance. Understanding the pathobiology and pathophysiology of adipose dysfunction in CVD or CKD will also shed light on potential diagnostic and therapeutic strategies of CVD or CKD targeting adipose tissue.
In this Research Topic, we seek to provide a forum for recent advances on various adipose tissues and adipokines function to identify major contributors of the adipose-vascular axis to obesity and metabolism-related diseases, especially CVD and CKD. We welcome all investigators in the field to submit their Original Research articles (basic and clinical studies), Reviews, and Perspectives. Potential topics include but are not limited to the following:
• Molecular and cellular pathobiology and pathophysiology of adipose dysfunction in CVD or CKD.
• Novel diagnostic and treatment strategies for CVD or CKD targeting adipose tissue.
• Emerging roles for adipose tissue in cardiovascular diseases, including arteriosclerosis and thrombosis.
• Current and novel therapeutic interventions to reduce CVD or CKD progression: lifestyle modification, pharmacological targets, bariatric surgery, drug discovery and repurposing.
Given the success of Research Topic
The Impact of Adipose Tissue Dysfunction on Cardiovascular and Renal Disease and the rapidly evolving subject area, we are pleased to announce the launch of Volume II.
Obesity is associated with adverse metabolic diseases, including cardiovascular disease (CVD) and chronic kidney disease (CKD). These obesity-related diseases were believed to be highly associated with excess fat accumulation in adipose tissue. However, emerging evidence has shown that body fat distribution plays a more important role in body metabolism and obesity-related metabolic diseases, compared with fat accumulation itself. Previous studies have focused mainly on classical visceral adipose tissue and subcutaneous adipose tissue. However, other adipose tissues around vessels, including perivascular adipose, perirenal adipose tissues, and epicardial tissues, have attracted much attention recently. This adipose tissue dysfunction has shown to be associated with a higher risk of CVD and CKD in obesity and metabolic syndrome. However, little is known about the mechanisms underlying this potential association. Hence, studies on the relationship of various adipose tissue dysfunction to metabolism-related diseases are of utmost importance. Understanding the pathobiology and pathophysiology of adipose dysfunction in CVD or CKD will also shed light on potential diagnostic and therapeutic strategies of CVD or CKD targeting adipose tissue.
In this Research Topic, we seek to provide a forum for recent advances on various adipose tissues and adipokines function to identify major contributors of the adipose-vascular axis to obesity and metabolism-related diseases, especially CVD and CKD. We welcome all investigators in the field to submit their Original Research articles (basic and clinical studies), Reviews, and Perspectives. Potential topics include but are not limited to the following:
• Molecular and cellular pathobiology and pathophysiology of adipose dysfunction in CVD or CKD.
• Novel diagnostic and treatment strategies for CVD or CKD targeting adipose tissue.
• Emerging roles for adipose tissue in cardiovascular diseases, including arteriosclerosis and thrombosis.
• Current and novel therapeutic interventions to reduce CVD or CKD progression: lifestyle modification, pharmacological targets, bariatric surgery, drug discovery and repurposing.
